Senior Marketing & Launch Director — Rare Disease, Remote

Travere Therapeutics; Wichita (KS); Hybrid; USD 219,000 - 285,000; Full time

Benefits offered by this job

Premium health benefits

Retirement plans with employer match

Stock options

Generous paid time off

Life insurance

Disability benefits

Job summary

Travere Therapeutics is seeking a Senior Director, Marketing & Launch Lead for pegtibatinase to develop and execute the U.S. commercial strategy and lead launch readiness for classical homocystinuria (HCU).

The role leads U.S. product strategy, oversees the PegT marketing organization, and partners with Patient Access, Medical Affairs, Regulatory, and other functions to ensure a successful market entry. Travel up to 30% is expected.

Qualifications

• Bachelor's degree in Business, Life Sciences, or related discipline; advanced degree preferred.
• 12+ years of biotechnology or pharmaceutical commercial experience with progression in responsibility.
• Significant U.S. marketing and product strategy experience in specialty or rare disease; rare metabolic disease experience preferred.
• Demonstrated experience preparing and launching products in the U.S.
• Experience leading marketing teams and cross-functional launch teams in a matrixed organization.

Responsibilities

• Lead the U.S. marketing strategy and execution for pegtibatinase across HCP, patient/caregiver, and patient services channels.
• Develop product positioning, patient and physician segmentation, messaging, and market development strategies.
• Build, lead, and develop the PegT U.S. marketing team and agency partnerships.
• Lead the integrated U.S. commercial launch plan across Patient Access, Sales, Commercial Insights & Operations, Medical Affairs, Patient Advocacy and Digital Strategy.

Skills

Strategic thinking

Executive communication

Cross-functional leadership

Launch management

Education

Bachelor's degree in Business/Life Sciences

Job description

Travere Therapeutics is seeking a Senior Director, Marketing & Launch Lead for pegtibatinase to develop and execute the U.S. commercial strategy and lead launch readiness for classical homocystinuria (HCU).

The role leads U.S. product strategy, oversees the PegT marketing organization, and partners with Patient Access, Medical Affairs, Regulatory, and other functions to ensure a successful market entry. Travel up to 30% is expected.